London, 18 February 2015: TechNavio, the independent tech-focused global research firm, has published a report on the Global POC Lipid Testing Market 2015-2019, which is expected to grow at a CAGR of 6.04 percent during the period 2014-2019.
“POC lipid testing can be used for routine checkup of the cholesterol level in the blood, including total cholesterol, LDL, HDL, and triglycerides,” says Faisal Ghaus, Vice President of TechNavio.
“POC lipid tests provide rapid results, thereby helping in making immediate treatment decisions. Thus, the length of patient stay in hospitals and backlog in areas such as emergency departments, where patients have to wait for test results, are reduced.”
Key Market Drivers
- Increase in Obesity and Cardiac Disorders
- Advances in Technology
- Increase in Aging Population
- Increased Global Healthcare Spending
Key Market Trends
- Increased Adoption of POC Lipid Testing
- Expanding Economy of APAC Region
- Increased M&A
Key Market Vendors
- Abbott Laboratories Inc.
- Alere Inc.
- F. Hoffmann-La Roche Ltd.
- PTS Diagnostics Inc.
To define the market circumstances in the next 3-4 years, TechNavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
